Know your enemy: translating insights about the molecular biology of hepatitis C virus into novel therapeutic approaches

Expert Review of Gastroenterology & Hepatology
Thomas von HahnThomas Pietschmann

Abstract

Identified in 1989 as the cause of what was then known as hepatitis non-A non-B, the hepatitis C virus (HCV) continues to be a significant global public health threat, given that an estimated 123 million individuals are chronically infected and, thus, at risk for cirrhosis and hepatocellular carcinoma. After 20 years of basic and clinical research into HCV infection, the backbone of therapy has remained interferon, a drug that - in a different formulation - was already being employed before HCV was even identified. Nonetheless, research has overcome many obstacles that stood in the way of studying this pre-eminent human pathogen. Hard-won insights into its molecular biology have identified promising therapeutic targets, and we are now on the verge of an era where rationally designed therapeutics, also referred to as specifically targeted antiviral therapy for HCV, will reshape the treatment of hepatitis C. This article describes recent insights on the molecular biology of HCV and the efforts to translate them into clinical applications.

References

Jan 1, 1992·Medical Microbiology and Immunology·R ThomssenA Uy
Dec 18, 1986·The New England Journal of Medicine·J H HoofnagleE A Jones
Mar 28, 1995·Proceedings of the National Academy of Sciences of the United States of America·A WeinerC M Walker
Feb 18, 1997·Proceedings of the National Academy of Sciences of the United States of America·G BarbaC Bréchot
Sep 18, 1997·The Journal of General Virology·J P MichalakJ Dubuisson
Oct 30, 1998·Science·P PileriS Abrignani
Feb 18, 1999·Journal of Medical Virology·M MonazahianR Thomssen
Oct 27, 1999·Proceedings of the National Academy of Sciences of the United States of America·V AgnelloQ X Zhang
Jul 15, 2000·Seminars in Liver Disease·A Wasley, M J Alter
Jul 25, 2000·Journal of Hepatology·L Rubbia-BrandtF Negro
Dec 9, 2000·Science·K J BlightC M Rice
Jan 11, 2001·Journal of Virology·V LohmannR Bartenschlager
Jun 26, 2001·Journal of Medical Virology·T KatoT Wakita
Aug 2, 2001·Nature Medicine·D F MercerN M Kneteman
Sep 1, 2001·Antiviral Research·R Bartenschlager, V Lohmann
Jan 17, 2002·The New England Journal of Medicine·E JaeckelUNKNOWN German Acute Hepatitis C Therapy Group
Sep 27, 2002·The New England Journal of Medicine·Michael W FriedJian Yu
Jan 9, 2003·Journal of Lipid Research·M Mahmood HussainPaul Dreizen
Feb 14, 2003·Journal of Virology·Volker LohmannRalf Bartenschlager
Mar 1, 2003·The Journal of Biological Chemistry·Pierre-Yves LozachRalf Altmeyer
Mar 5, 2003·The Journal of Experimental Medicine·Birke BartoschFrançois-Loïc Cosset
Mar 14, 2003·Journal of Virology·Stefan PöhlmannJane A McKeating
Apr 30, 2003·Proceedings of the National Academy of Sciences of the United States of America·Davor PavlovićNicole Zitzmann
May 23, 2003·Proceedings of the National Academy of Sciences of the United States of America·Mayla HsuJane A McKeating
Jul 2, 2003·FEBS Letters·Heidi E DrummerPantelis Poumbourios
Jul 10, 2003·Gastroenterology·J Tilman GerlachGerd R Pape
Jul 18, 2003·The Journal of Biological Chemistry·Heidi BarthThomas F Baumert
Sep 25, 2003·Proceedings of the National Academy of Sciences of the United States of America·Akito SakaiJens Bukh
Oct 28, 2003·Nature Structural Biology·Peter J LukavskyJoseph D Puglisi
Jan 16, 2004·Gastroenterology·Takanobu KatoTakaji Wakita
Mar 3, 2004·The Journal of Biological Chemistry·Tomoko DateTakaji Wakita
May 5, 2004·Proceedings of the National Academy of Sciences of the United States of America·Emmanuel G CormierTatjana Dragic
Jul 1, 2004·Alimentary Pharmacology & Therapeutics·J DelwaideUNKNOWN Belgian Association for the Study of the Liver (BASL)
Sep 17, 2004·Proceedings of the National Academy of Sciences of the United States of America·Emmanuel G CormierTatjana Dragic

❮ Previous
Next ❯

Citations

Aug 27, 2011·Clinics in Liver Disease·Sandra CiesekMichael P Manns
Dec 23, 2011·Journal of Viral Hepatitis·S Ciesek, H Wedemeyer
Jul 1, 2016·Journal of Medical Microbiology·Sanjim ChadhaS Venkatesh
Jun 5, 2020·Transplant Infectious Disease : an Official Journal of the Transplantation Society·Giada PietrosiPier Giulio Conaldi
Mar 9, 2013·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Suresh D Sharma
Jan 12, 2016·Biomolecules·Ellis L RyanRoger J Grand

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Carcinoma, Hepatocellular

Hepatocellular Carcinoma is a malignant cancer in liver epithelial cells. Discover the latest research on Hepatocellular Carcinoma here.